Skip to main content
Log in

Large cardiac metastasis from pancreatic neuroendocrine tumor and response to peptide receptor radionuclide therapy with 177Lu-DOTATATE

  • Images that Teach
  • Published:
Journal of Nuclear Cardiology Aims and scope

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Figure 1

References

  1. Carreras C, Kulkarni HR, Baum RP. Rare metastases detected by (68)Ga-somatostatin receptor PET/CT in patients with neuroendocrine tumors. Recent Results Cancer Res. 2013;94:379–84.

    Article  Google Scholar 

  2. Collins N, Bellamy G, Hayes P. Intrapericardial carcinoid metastasis. J Am Soc Echocardiogr. 2004;1(7):675–6.

    Article  Google Scholar 

  3. Pandya UH, Pellikka PA, Enriquez-Sarano M, Edwards WD, Schaff HV, Connolly HM. Metastatic carcinoid tumor to the heart: echocardiographic–pathologic study of 11 patients. J Am Coll Cardiol. 2002;40:1328–32.

    Article  Google Scholar 

Download references

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Sandip Basu Diplomate N.B..

Ethics declarations

Disclosure

All authors declare that they have no conflict of interest.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Parghane, R.V., Basu, S. Large cardiac metastasis from pancreatic neuroendocrine tumor and response to peptide receptor radionuclide therapy with 177Lu-DOTATATE. J. Nucl. Cardiol. 27, 340–341 (2020). https://doi.org/10.1007/s12350-018-1426-1

Download citation

  • Received:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1007/s12350-018-1426-1

Keywords

Navigation